Annual accounts
Total Exemption Full accounts
30/09/2027Filing deadline
Made up to 31/12/2025Due 30/09/2027
- Next accounts made up to
- 31/12/2026
- Last accounts made up to
- 31/12/2025
RIDGE PHARMA LIMITED
ActiveRegistry details
Reference data exactly as held at Companies House.
Copy registry details
- Registered office
- 12 Park Lane, Tilehurst, Reading, Berkshire RG31 5DL
- Classification (SIC)
- Other human health activities (86.90 - SIC 2007)
- Accounts type
- Total Exemption Full
Company activity
The 4 most recent documents filed at Companies House.
Pre-Score for UK companies is coming soon
- 17/07/2026View PDF (1 pages)
Termination of appointment of Brian Alexander Mcewan as a director on 2026-07-16
- 17/07/2026View PDF (1 pages)
Termination of appointment of Harry Thomas Stratford as a director on 2026-07-16
- 03/02/2026View PDF (3 pages)
Confirmation statement made on 2026-01-20 with no updates
- 25/09/2025View PDF (1 pages)
Termination of appointment of Martijn Christian Kleibergen as a director on 2025-09-17
Coming soon
What Pre-Score will tell you
- Whether the filed accounts are strengthening or weakening year on year.
- Whether this company files on time, and how often its record changes.
- How its officers and controlling parties connect to other UK companies.
Accounts and confirmation statement
The two filings Companies House requires every year, and where each one stands against its deadline today.
On schedule
Confirmation statement
Confirms the registry record is up to date
03/02/2027Filing deadline
Last statement 20/01/2026Due 03/02/2027
- Next statement date
- 20/01/2027
- Last statement dated
- 20/01/2026
Financial performance
The latest figures RIDGE PHARMA LIMITED filed. Okredo holds filed accounts data for 2021–2024; the year-by-year record is on the financials page.
Net Assets
£665.50K2024
-5.15%vs 20232023: £701.66K
Total Assets
£2.63M2024
19.43%vs 20232023: £2.20M
Cash in Bank
£477.53K2024
-10.73%vs 20232023: £534.92K
Total Liabilities
£1.96M2024
30.95%vs 20232023: £1.50M
Employees
222024
0vs 20232023: 22
Of the 4 measures with an earlier filing to compare against, 2 rose and 2 fell. Total liabilities moved furthest, up 30.95% on 2023. See the full financial analysis for RIDGE PHARMA LIMITED.
The full financial record
Four ways through RIDGE PHARMA LIMITED's filed accounts — the year-by-year numbers, the compound rates and the ratios behind them.
Net Assets · -13.4% a year (CAGR)Three-year trend, 2022–2024Every measure end to end across 2022, 2023 and 2024, with the compound rate behind each one.See what moved5 chartsCharts by indicator5 filed indicators plotted year by year, 2021–2024.Plot the figuresNothing estimatedRatios from the filed figures4 ratios computed from this company's own reported amounts, each shown against the year it was derived from.Check the ratios5 × 4 yearsEvery figure by yearAll 5 measures Okredo tracks across 4 reported years, exactly as filed.Open the table
Employees
Headcount as reported to Companies House for 2021–2024.
| Year | Employees | Change |
|---|---|---|
| 2024 | 22 | 0 |
| 2023 | 22 | +1 |
| 2022 | 21 | +8 |
| 2021 | 13 | – |
Reported employee count increased from 13 in 2021 to 22 in 2024. See how headcount moved alongside the reported financials.
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
- Company potential
- Risk indicators
- Past performance
- Future prospects
Officers
14Directors, secretaries and other appointed officers, with the period each has served.
| Person | Role | Period | Connected companies |
|---|---|---|---|
| Director | 29/07/2022–07/08/2023 | 6 | |
| Corporate Director | 17/09/2025–Present | 153 | |
| Director | 23/06/2017–16/07/2026 | 6 | |
| Director | 10/02/2017–10/02/2017 | 6 | |
| Director | 04/09/2018–31/12/2019 | 47 | |
| Director | 01/02/2020–Present | 7 | |
| Director | 07/08/2023–17/09/2025 | 105 | |
| Director | 01/07/2019–30/03/2020 | 29 | |
| Director | 22/10/2020–16/07/2026 | 8 | |
| Director | 08/03/2024–Present | 0 | |
| Director | 10/02/2017–04/09/2018 | 1 | |
| Director | 10/02/2017–Present | 0 | |
| Director | 04/09/2018–31/10/2018 | 52 | |
| Director | 31/10/2018–29/07/2022 | 5 |
Persons with significant control
3Individuals or entities with significant control over the company, as declared to Companies House.
| Person | Period | Connected companies |
|---|---|---|
| 23/07/2018–08/08/2018 | 6 | |
| 23/07/2018–08/08/2018 | 1 | |
| 10/02/2017–23/07/2018 | 0 |
Filing history and recent activity
Every document on the Companies House record, newest first.
- Filings on record
- 28
- Since 18/07/2017
- Last 12 months
- 3
- -2 vs the year before
- Most recent filing
- 17/07/2026
- 2 months ago
What changed in the last year
- Officer changes (2)Latest 17/07/2026
- Confirmation statementLatest 03/02/2026
Filing timeline
- 17/07/2026View PDF (1 pages)
Termination of appointment of Brian Alexander Mcewan as a director on 2026-07-16
- 17/07/2026View PDF (1 pages)
Termination of appointment of Harry Thomas Stratford as a director on 2026-07-16
- 03/02/2026View PDF (3 pages)
Confirmation statement made on 2026-01-20 with no updates
- 25/09/2025View PDF (1 pages)
Termination of appointment of Martijn Christian Kleibergen as a director on 2025-09-17
- 25/09/2025View PDF (2 pages)
Appointment of Mercia Fund Management (Nominees) Limited as a director on 2025-09-17
- 17/07/2025View PDF (10 pages)
Total exemption full accounts made up to 2024-12-31
- 23/05/2025View PDF (33 pages)
Registration of charge 106126870003, created on 2025-05-20
- 27/01/2025View PDF (3 pages)
Confirmation statement made on 2025-01-20 with no updates
- 19/08/2024View PDF (30 pages)
Registration of charge 106126870002, created on 2024-08-05
- 07/06/2024View PDF (10 pages)
Total exemption full accounts made up to 2023-12-31
- 08/03/2024View PDF (2 pages)
Appointment of Ms Tasmin Lizabeth Morgan as a director on 2024-03-08
- 22/01/2024View PDF (3 pages)
Confirmation statement made on 2024-01-20 with no updates
Showing 12 of 28 filings
See when the next accounts and confirmation statement are due
Similar companies
263 UK companies are similar to RIDGE PHARMA LIMITED, sharing the same company status (Active), the same industry sector and activity group (Other human health activities) and a comparable number of employees. The 5 closest matches are shown below to help you compare competitors and industry peers.
CARE 4U SERVICES (MIDLANDS) LTD
Active7 Edison Buildings, Electric Wharf, Coventry CV1 4JA
- Activity
- Other human health activities
- Company no.
- 06390885
- Incorporated
- 05/10/2007
- Employees
- 24
APIAN LIMITED
ActiveApian, 2-6 Boundary Row, Southwark SE1 8HP
- Activity
- Other human health activities
- Company no.
- 12578044
- Incorporated
- 29/04/2020
- Employees
- 21
RAVENSCROFT HEALTHCARE LIMITED
Active266 High Road, Harrow, Middlesex HA3 7BB
- Activity
- Other human health activities
- Company no.
- 06413262
- Incorporated
- 30/10/2007
- Employees
- 21
PHOENIX CARE 91 LTD
ActiveBroadway House, 2 Haygate Road, Wellington TF1 1QA
- Activity
- Other human health activities
- Company no.
- 12957841
- Incorporated
- 16/10/2020
- Employees
- 25
3SIXTY CARE LIMITED
ActiveSt Mary's Hospital, Huxlow House, London Road, Kettering NN15 7PW
- Activity
- General medical practice activities
- Company no.
- 09145459
- Incorporated
- 24/07/2014
- Employees
- 20
About RIDGE PHARMA LIMITED
A short description of the company, written from its Companies House record.
RIDGE PHARMA LIMITED is a private limited company registered in the United Kingdom, based in 12 Park Lane, Tilehurst, Reading, Berkshire RG31 5DL. Companies House classifies its business as Other human health activities. It has been on the register for 9 years 7 months.
The register currently records it as active. Its 2024 accounts report net assets of £665.50K and 22 employees.
RIDGE PHARMA LIMITED: frequently asked questions
Answered from this company's own registry record and filed figures.
Companies House records RIDGE PHARMA LIMITED under one registered business activity: Other human health activities (86.90 - SIC 2007).
RIDGE PHARMA LIMITED is recorded as active on the Companies House register, and has been on it since 10/02/2017.
The most recent accounts Okredo holds cover 2024 and report net assets of £665.50K, total assets of £2.63M, cash in bank of £477.53K and total liabilities of £1.96M.
The most recent document on the record is dated 17/07/2026: Termination of appointment of Brian Alexander Mcewan as a director on 2026-07-16, 2 months ago.
On the current registry record, accounts are due by 30/09/2027 and the next confirmation statement is due by 03/02/2027.
Companies House lists 14 officers (4 currently in post) and 3 people with significant control (0 current).